192 related articles for article (PubMed ID: 29391559)
1. Substitutions of the S4DIV R2 residue (R1451) in Na
Poulin H; Gosselin-Badaroudine P; Vicart S; Habbout K; Sternberg D; Giuliano S; Fontaine B; Bendahhou S; Nicole S; Chahine M
Sci Rep; 2018 Feb; 8(1):2041. PubMed ID: 29391559
[TBL] [Abstract][Full Text] [Related]
2. N1366S mutation of human skeletal muscle sodium channel causes paramyotonia congenita.
Ke Q; Ye J; Tang S; Wang J; Luo B; Ji F; Zhang X; Yu Y; Cheng X; Li Y
J Physiol; 2017 Nov; 595(22):6837-6850. PubMed ID: 28940424
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization and cold sensitivity of T1313A, a new mutation of the skeletal muscle sodium channel causing paramyotonia congenita in humans.
Bouhours M; Sternberg D; Davoine CS; Ferrer X; Willer JC; Fontaine B; Tabti N
J Physiol; 2004 Feb; 554(Pt 3):635-47. PubMed ID: 14617673
[TBL] [Abstract][Full Text] [Related]
4. A204E mutation in Na
Kokunai Y; Dalle C; Vicart S; Sternberg D; Pouliot V; Bendahhou S; Fournier E; Chahine M; Fontaine B; Nicole S
Sci Rep; 2018 Nov; 8(1):16681. PubMed ID: 30420713
[TBL] [Abstract][Full Text] [Related]
5. Cold-induced defects of sodium channel gating in atypical periodic paralysis plus myotonia.
Webb J; Cannon SC
Neurology; 2008 Mar; 70(10):755-61. PubMed ID: 17898326
[TBL] [Abstract][Full Text] [Related]
6. Hypokalaemic periodic paralysis and myotonia in a patient with homozygous mutation p.R1451L in Na
Luo S; Sampedro Castañeda M; Matthews E; Sud R; Hanna MG; Sun J; Song J; Lu J; Qiao K; Zhao C; Männikkö R
Sci Rep; 2018 Jun; 8(1):9714. PubMed ID: 29946067
[TBL] [Abstract][Full Text] [Related]
7. Overlap of periodic paralysis and paramyotonia congenita caused by SCN4A gene mutations two family reports and literature review.
Huang S; Zhang W; Chang X; Guo J
Channels (Austin); 2019 Dec; 13(1):110-119. PubMed ID: 30931713
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands.
Stunnenberg BC; Raaphorst J; Deenen JCW; Links TP; Wilde AA; Verbove DJ; Kamsteeg EJ; van den Wijngaard A; Faber CG; van der Wilt GJ; van Engelen BGM; Drost G; Ginjaar HB
Neuromuscul Disord; 2018 May; 28(5):402-407. PubMed ID: 29606556
[TBL] [Abstract][Full Text] [Related]
9. Altered fast and slow inactivation of the N440K Nav1.4 mutant in a periodic paralysis syndrome.
Lossin C; Nam TS; Shahangian S; Rogawski MA; Choi SY; Kim MK; Sunwoo IN
Neurology; 2012 Sep; 79(10):1033-40. PubMed ID: 22914841
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of myotonic hNav1.4 sodium channel variants situated near the fast inactivation gate.
Farinato A; Altamura C; Imbrici P; Maggi L; Bernasconi P; Mantegazza R; Pasquali L; Siciliano G; Lo Monaco M; Vial C; Sternberg D; Carratù MR; Conte D; Desaphy JF
Pharmacol Res; 2019 Mar; 141():224-235. PubMed ID: 30611854
[TBL] [Abstract][Full Text] [Related]
11. The human skeletal muscle Na channel mutation R669H associated with hypokalemic periodic paralysis enhances slow inactivation.
Struyk AF; Scoggan KA; Bulman DE; Cannon SC
J Neurosci; 2000 Dec; 20(23):8610-7. PubMed ID: 11102465
[TBL] [Abstract][Full Text] [Related]
12. Changes of Resurgent Na
Huang CW; Lai HJ; Lin PC; Lee MJ
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32276507
[TBL] [Abstract][Full Text] [Related]
13. Divalent cation-responsive myotonia and muscle paralysis in skeletal muscle sodium channelopathy.
Mankodi A; Grunseich C; Skov M; Cook L; Aue G; Purev E; Bakar D; Lehky T; Jurkat-Rott K; Pedersen TH; Childs RW
Neuromuscul Disord; 2015 Nov; 25(11):908-12. PubMed ID: 26494408
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of genetically confirmed skeletal muscle channelopathies in the era of next generation sequencing.
Vivekanandam V; Jaibaji R; Sud R; Ellmers R; Skorupinska I; Germaine L; James N; Holmes S; Mannikko R; Jayaseelan D; Hanna MG
Neuromuscul Disord; 2023 Mar; 33(3):270-273. PubMed ID: 36796140
[TBL] [Abstract][Full Text] [Related]
15. Clinical comparison and functional study of the L703P: a recurrent mutation in human SCN4A that causes sodium channel myotonia.
Ke Q; Zhao Y; Li Y; Ye J; Tang S; He F; Ji F; Dai X; Ni J; Li Y; Griggs RC; Cheng X
Neuromuscul Disord; 2022 Oct; 32(10):811-819. PubMed ID: 36050252
[TBL] [Abstract][Full Text] [Related]
16. New mutation of the Na channel in the severe form of potassium-aggravated myotonia.
Kubota T; Kinoshita M; Sasaki R; Aoike F; Takahashi MP; Sakoda S; Hirose K
Muscle Nerve; 2009 May; 39(5):666-73. PubMed ID: 19347921
[TBL] [Abstract][Full Text] [Related]
17. Spider toxin inhibits gating pore currents underlying periodic paralysis.
Männikkö R; Shenkarev ZO; Thor MG; Berkut AA; Myshkin MY; Paramonov AS; Kulbatskii DS; Kuzmin DA; Sampedro Castañeda M; King L; Wilson ER; Lyukmanova EN; Kirpichnikov MP; Schorge S; Bosmans F; Hanna MG; Kullmann DM; Vassilevski AA
Proc Natl Acad Sci U S A; 2018 Apr; 115(17):4495-4500. PubMed ID: 29636418
[TBL] [Abstract][Full Text] [Related]
18. Sodium Channelopathies of Skeletal Muscle.
Cannon SC
Handb Exp Pharmacol; 2018; 246():309-330. PubMed ID: 28939973
[TBL] [Abstract][Full Text] [Related]
19. A1152D mutation of the Na+ channel causes paramyotonia congenita and emphasizes the role of DIII/S4-S5 linker in fast inactivation.
Bouhours M; Luce S; Sternberg D; Willer JC; Fontaine B; Tabti N
J Physiol; 2005 Jun; 565(Pt 2):415-27. PubMed ID: 15790667
[TBL] [Abstract][Full Text] [Related]
20. Hyperkalemic periodic paralysis associated with a novel missense variant located in the inner pore of Nav1.4.
Segawa K; Nishiyama M; Mori I; Kubota T; Takahashi MP
Brain Dev; 2023 Apr; 45(4):205-211. PubMed ID: 36628799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
